Drug Reference
Carbidopa / Levodopa
Brand names
CrexontDhivyDuopaRytarySinemetVyalev
Available as
4.63 MG/ML · Oral Suspension23.75 MG · Extended Release Oral Capsule36.25 MG · Extended Release Oral Capsule48.75 MG · Extended Release Oral Capsule61.25 MG · Extended Release Oral Capsule10 MG · Oral Tablet25 MG · Oral Tablet12.5 MG · Oral Tablet35 MG · Extended Release Oral Capsule52.5 MG · Extended Release Oral Capsule70 MG · Extended Release Oral Capsule87.5 MG · Extended Release Oral Capsule10 ML · Injection25 MG · Extended Release Oral Tablet50 MG · Extended Release Oral Tablet25 MG · Disintegrating Oral Tablet10 MG · Disintegrating Oral Tablet
Multi-ingredient product
CarbidopaLevodopa
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [RADHA PHARMACEUTICALS INC]
- CARBIDOPA AND LEVODOPA TABLET [AVPAK]
- CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMACEUTICAL INDUSTRIES, INC.]
- CARBIDOPA AND LEVODOPA TABLET [WESTMINSTER PHARMACEUTICALS, LLC]
- CARBIDOPA AND LEVODOPA TABLET [MAJOR PHARMACEUTICALS]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.